Form 4: Health Catalyst CPO Sells Shares for Tax Obligations

Health Catalyst's Chief People Officer, Linda Llewelyn, sold 2,854 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Summary

• Linda Llewelyn, Chief People Officer of Health Catalyst, Inc. (HCAT), reported a disposition of common stock.
• The transaction involved the sale of 2,854 shares of common stock on September 2, 2025.
• The shares were sold at a price of $3.3627 per share.
• This sale was not a discretionary trade but was mandated by the Issuer's equity incentive plans to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs).
• Following this transaction, Linda Llewelyn beneficially owns 153,025 shares of Health Catalyst common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary 'sell to cover' for tax obligations, which is a neutral event and does not indicate positive or negative sentiment towards the company's prospects.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

This is a routine insider transaction (sell-to-cover) and does not provide specific insights into broader industry trends or competitive positioning for Health Catalyst.

Stakeholder Impact

• Shareholders: The sale is a routine, non-discretionary event for tax purposes and is unlikely to have a significant direct impact on shareholder value or perception. It reflects standard equity compensation practices.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary 'sell to cover' transaction by a corporate officer to satisfy tax obligations upon RSU vesting. Such transactions are common and do not reflect a discretionary investment decision by the insider, nor do they typically provide new material information about the company's operational performance or future outlook. Therefore, based solely on this filing, there is no new information to warrant a change from a 'hold' recommendation.

Keywords

Health Catalyst, HCAT, Linda Llewelyn, Chief People Officer, Form 4, Insider Transaction, Stock Sale, Restricted Stock Units, Tax Withholding